POC血糖検査市場：製品別、購入形態別、エンドユーザー別-2025～2030年世界予測

POC血糖検査市場は、2023年に67億米ドルと評価され、2024年には72億米ドルに達すると予測され、CAGR 7.54％で成長し、2030年には111億5,000万米ドルに達すると予測されています。

POC血糖検査（POCT）の範囲には、病院、クリニック、家庭環境などさまざまな環境で糖尿病のタイムリーな管理を可能にし、即座にグルコースレベルの測定値を提供するという重要な役割が含まれます。POCTの必要性は、糖尿病の有病率の増加と合併症を予防するための定期的なモニタリングの必要性から生じています。POCTの用途は、糖尿病患者の自己モニタリング、臨床現場や救急現場での糖尿病管理、グルコースコントロールが重要な手術中や救命処置中など多岐にわたります。最終用途の範囲には主に病院、クリニック、在宅医療が含まれ、利便性と健康管理における患者のエンパワーメントの高まりから在宅検査への動向が高まっています。

市場の主要成長要因としては、世界の糖尿病罹患率の上昇、非侵襲性モニターなどの検査機器の技術進歩、医療支出の増加などが挙げられます。ビジネス機会は主に、医療インフラが整備され、糖尿病人口が増加している新興市場にあり、そこでは手頃な価格で使いやすいPOCTデバイスが大きな効果をもたらす可能性があります。こうした機会を捉えるための推奨事項としては、製品の差別化のための技術革新の活用、ユーザーフレンドリーなインターフェースの重視、市場拡大と流通のための戦略的パートナーシップの構築などが挙げられます。

しかし、市場成長は、規制上の課題、先進的検査機器の高コスト、持続グルコースモニターのような代替技術との競合といった限界に直面しています。また、デジタルPOCTソリューションにおけるデータ管理に関連したプライバシーの問題もあります。技術革新の可能性があるセグメントには、非侵襲的検査法の開発、予測分析とリアルタイムモニタリングのためのAIの統合、機器の携帯性と接続性の改善などがあります。こうした道を探ることで、患者のコンプライアンスが強化され、より広範な導入につながる可能性があります。市場の性質はダイナミックでありながら細分化されており、破壊的な技術を提供する新規参入の可能性が大きいです。このセグメントで事業を持続的に成長させるためには、重点的な研究開発と地域別の市場力学の理解が不可欠です。

市場力学：急速に進化するPOC血糖検査市場の主要市場洞察を公開

POC血糖検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病患者の増加
  • グルコースのモニタリングにおけるデータ管理プログラムの組み込みの増加
  • 先進国と新興諸国における在宅医療需要の高まり
• 市場抑制要因
  • 製品開発コストの高さ
• 市場機会
  • より良い検査のためのデジタル技術の統合
  • サプライチェーンと流通網の拡大
• 市場課題
  • グルコースメーターにおける干渉の可能性と校正の問題

ポーターのファイブフォース：POC血糖検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：POC血糖検査市場における外部からの影響の把握

外部マクロ環境要因は、POC血糖検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：POC血糖検査市場における競合情勢の把握

POC血糖検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：POC血糖検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、POC血糖検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：POC血糖検査市場における成功への道筋を描く

POC血糖検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病患者の有病率の増加
    • 血糖値モニタリングにおけるデータ管理プログラムの導入が増加
    • 先進国と新興諸国における在宅医療の需要の高まり
  • 抑制要因
    • 製品開発コストが高い
  • 機会
    • より良いテストのためのデジタル技術の統合
    • サプライチェーンと流通ネットワークの拡大
  • 課題
    • 血糖値測定器における潜在的な干渉と校正の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 POC血糖検査市場：製品別

• イントロダクション
• Accu Check Aviva Meter
• Accu-Chek Inform II
• Bayerコンター血糖モニタリングシステム
• Freestyle Lite
• i-STAT
• Onetouch Verio Flex
• StatStrip
• True Metrix

第7章 POC血糖検査市場：購入形態別

• イントロダクション
• 市販の検査製品
• 処方箋の検査製品

第8章 POC血糖検査市場：エンドユーザー別

• イントロダクション
• 在宅医療
• 病院と救命救急センター
• 外来・通院ケア施設

第9章 南北アメリカのPOC血糖検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のPOC血糖検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのPOC血糖検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AccubIoTech Co. Ltd.
• ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
• Bio-Rad Laboratories
• Danaher Corporation
• EKF Diagnostics by IBL PLC
• F. Hoffmann-La Roche Ltd.
• Fluxergy
• LifeScan, Inc.
• Medtronic PLC
• Nipro Corporation
• Nova Biomedical Corporation
• Prodigy Diabetes Care, LLC.
• Siemens Healthineers AG
• Sinocare

LIST OF FIGURES

• FIGURE 1. POINT-OF-CARE GLUCOSE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Point-of-Care Glucose Testing Market was valued at USD 6.70 billion in 2023, expected to reach USD 7.20 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 11.15 billion by 2030.

The scope of Point-of-Care Glucose Testing (POCT) encompasses its critical role in providing immediate glucose level readings, enabling timely management of diabetes in various settings such as hospitals, clinics, and home environments. The necessity of POCT arises from the growing prevalence of diabetes and the need for regular monitoring to prevent complications. Its applications span across self-monitoring for individuals with diabetes, diabetes management in clinical and emergency settings, and during surgeries or critical care where glucose control is vital. The end-use scope largely includes hospitals, clinics, and home care, with an increasing trend toward home testing due to convenience and rising patient empowerment in managing health.

Key growth influencers in the market include the rising incidence of diabetes globally, technological advancements in testing devices such as non-invasive monitors, and increased healthcare spending. Opportunities mainly lie in emerging markets with growing healthcare infrastructure and a rising diabetic population, where affordable and easy-to-use POCT devices can make a significant impact. Recommendations for capturing these opportunities include leveraging technological innovations for product differentiation, focusing on user-friendly interfaces, and forging strategic partnerships for market expansion and distribution.

However, market growth faces limitations like regulatory challenges, high cost of advanced testing devices, and competition from alternative technologies like continuous glucose monitors. There are also privacy concerns related to data management in digital POCT solutions. Areas poised for innovation include the development of non-invasive testing methods, integration of AI for predictive analytics and real-time monitoring, and improvements in device portability and connectivity. Exploring these avenues can lead to enhanced patient compliance and broader adoption. The market's nature is dynamic yet fragmented, with significant potential for new entrants offering disruptive technologies. Focused R&D and an understanding of regional market dynamics are crucial for sustained business growth in this sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point-of-Care Glucose Testing Market

The Point-of-Care Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the prevalence rate of diabetic patients
  • Growing incorporation of data management programs in the monitoring of glucose
  • Growing demand for home healthcare from developed and developing countries
• Market Restraints
  • High cost of product development
• Market Opportunities
  • Integration of digital technologies for better testing
  • Expansion of supply chain and distribution networks
• Market Challenges
  • Potential interference and calibration issues in glucose meters

Porter's Five Forces: A Strategic Tool for Navigating the Point-of-Care Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point-of-Care Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point-of-Care Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point-of-Care Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point-of-Care Glucose Testing Market

A detailed market share analysis in the Point-of-Care Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point-of-Care Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point-of-Care Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point-of-Care Glucose Testing Market

A strategic analysis of the Point-of-Care Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point-of-Care Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio-Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, Prodigy Diabetes Care, LLC., Siemens Healthineers AG, and Sinocare.

Market Segmentation & Coverage

This research report categorizes the Point-of-Care Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, i-STAT, Onetouch Verio Flex, StatStrip, and True Metrix.
• Based on Mode of Purchase, market is studied across OTC Testing Product and Prescription-Based Testing Product.
• Based on End-User, market is studied across Home Care Settings, Hospitals & Critical Care Centers, and Outpatient & Ambulatory Care Facilities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the prevalence rate of diabetic patients
    • 5.1.1.2. Growing incorporation of data management programs in the monitoring of glucose
    • 5.1.1.3. Growing demand for home healthcare from developed and developing countries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of product development
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of digital technologies for better testing
    • 5.1.3.2. Expansion of supply chain and distribution networks
  • 5.1.4. Challenges
    • 5.1.4.1. Potential interference and calibration issues in glucose meters
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Point-of-Care Glucose Testing Market, by Product

• 6.1. Introduction
• 6.2. Accu Check Aviva Meter
• 6.3. Accu-Chek Inform II
• 6.4. Bayer Contour Blood Glucose Monitoring System
• 6.5. Freestyle Lite
• 6.6. i-STAT
• 6.7. Onetouch Verio Flex
• 6.8. StatStrip
• 6.9. True Metrix

7. Point-of-Care Glucose Testing Market, by Mode of Purchase

• 7.1. Introduction
• 7.2. OTC Testing Product
• 7.3. Prescription-Based Testing Product

8. Point-of-Care Glucose Testing Market, by End-User

• 8.1. Introduction
• 8.2. Home Care Settings
• 8.3. Hospitals & Critical Care Centers
• 8.4. Outpatient & Ambulatory Care Facilities

9. Americas Point-of-Care Glucose Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Point-of-Care Glucose Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Point-of-Care Glucose Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accubiotech Co. Ltd.
• 3. ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
• 4. Bio-Rad Laboratories
• 5. Danaher Corporation
• 6. EKF Diagnostics by IBL PLC
• 7. F. Hoffmann-La Roche Ltd.
• 8. Fluxergy
• 9. LifeScan, Inc.
• 10. Medtronic PLC
• 11. Nipro Corporation
• 12. Nova Biomedical Corporation
• 13. Prodigy Diabetes Care, LLC.
• 14. Siemens Healthineers AG
• 15. Sinocare